Improved radiation therapy methods
CA 2659664 C · Owner: University Of Southern California · Inventors: Dizerega, Gere; Rodgers, Kathleen E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods and kits for mitigating radiation induced tissue damage improving the effectiveness of radiation therapy to support bone marrow transplantation and promoting megakaryocyte production and mobilization and platelet production each method comprising the administration of an effective amount of angiotensinogen angiotensin I(AI), AI analogues, AI fragments and analogues thereof angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 1999 and granted May 7, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 8, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.